April 1, 2020 NIAID Funding News

Read this full edition online at http://www.niaid.nih.gov/grants-contracts/funding-news-notices

Feature Articles

Updates on NIAID Funding for SARS-CoV-2 and COVID-2019 Research

We strongly encourage NIAID grantees developing applications in response to the NIAID Urgent Notice of Special Interest (NOSI) to transition to the NIAID Emergency NOSI instead.

Opportunities and Resources

New R01 Opportunity Allows up to Seven-Year Investigator-Initiated Clinical Trials

Several factors may necessitate an investigator-initiated clinical trial project period longer than five years, such as known difficulties with participant recruitment or retention.

A Pair of HIV-Related R01 Funding Opportunity Announcements

Consider research opportunities on the topics of vaccine science to improve tuberculosis treatment outcomes and harnessing natural killer cells to prevent, control, or eradicate HIV infection.

Compete in NIH’s Global Disease Diagnostics Prize Challenge

The Challenge rewards and spurs development of platform concepts and prototypes of noninvasive, multiplexed diagnostic technologies, ultimately reducing the public health impact of at least one of the three priority diseases.

Help Support Discovery of Next Generation HIV-1 Vaccine Through Engineering Immunity

NIAID seeks research that integrates, adapts, and optimizes various existing and emerging bioengineering approaches to provide breakthroughs that accelerate the development of a safe, efficacious HIV-1 vaccine.

In The News

CSR Considers Simplifying Review Criteria

NIH's Center for Scientific Review (CSR) has convened a new working group to consider changes to the peer review criteria for R01 research project grants and invites your feedback and questions.

NIH Highlights Progress of the Diversity Project Consortium

In a recent Science letter, Dr. Hannah Valantine and NIH Director Dr. Francis Collins describe several program outcomes from NIH’s Diversity Project Consortium.

Advice Corner

Requesting Assignments From the Center for Scientific Review

By using the optional PHS Assignment Request Form, you can convey your preferences for the locus of your application's peer review and the scientific expertise needed to review your application.

Reader Questions

New Funding Opportunities

PAR-20-158, Innovation for HIV Vaccine Discovery (R01, Clinical Trial Not Allowed)
RFA-AI-20-020, Tuberculosis Research Units (U19, Clinical Trial Optional)
NOT-AI-20-031, Notice of Special Interest (NOSI): Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
NOT-AI-20-034, Notice of Special Interest (NOSI) Regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
RFA-AI-20-007, Asthma and Allergic Diseases Cooperative Research Centers (U19, Clinical Trial Optional)
RFA-AI-20-024, Long Acting Treatments for HIV and HIV-Associated Co-Infections (R61/R33, Clinical Trial Not Allowed)
PA-20-142, Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)